Severe novel H1N1 influenza A infection in the immediate postoperative period of a liver transplant patient

Liver Transplantation

Volumn 16, Issue 4, 2010, Pages 447-452

  Zapata, Rodrigo ^a   Uribe, Mario ^a   Martínez, Waldo ^a   Andrade, Alejandro ^a   Leal, José Luis ^a   Gomez, Fernando ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; OSELTAMIVIR; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN; VORICONAZOLE; ANTIVIRUS AGENT; PRIMER DNA;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; DRUG DOSE REDUCTION; HUMAN; INFLUENZA; INFLUENZA VIRUS A H1N1; INTENSIVE CARE; LIVER CIRRHOSIS; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MALE; PNEUMONIA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; TRANSTHORACIC ECHOCARDIOGRAPHY; CHEMISTRY; COMPLICATION; IMMUNOLOGY; INFLUENZA, HUMAN; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROCEDURES; TIME; TREATMENT OUTCOME;

ANTIVIRAL AGENTS; DNA PRIMERS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; OSELTAMIVIR; POLYMERASE CHAIN REACTION; POSTOPERATIVE PERIOD; TIME FACTORS; TREATMENT OUTCOME;

EID: 77950633678     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.22013     Document Type: Article

References (16)

1. World Health Organization. Pandemic (H1N1) 2009-update 69. http://www.who.int/csr/don/2009-10-09/en/index.html. Accessed January 2010.
2. Gallaher WR. Towards a sane and rational approach to management of influenza H1N1 2009. Virol J 2009;6:51-58.
3. Chile Ministry of Health. The influenza pandemic 2009. Weekly report. http://www.redsalud.gov.cl/minsalaudios/reporte6octubre.pdf. Published October 6, 2009. Accessed January 2010.
4. Depoortere E, Manterol J, Lenglet E, Kreidl P, Coulombier D. Influenza A H1N1 in the southern hemisphere - lessons to learn for Europe? http://www.eurosurveillance.org/images/dynamic/EE/V14N24/art19246.pdf. Accessed January 2010.
5. Kumar D, Humar D. Pandemic influenza and its implications for transplantation. Am J Transplant 2006;6:1512-1517.
6. Duchini A, Goss JA, Karpen S, Pockros PJ. Vaccinations for adult solid-organ transplant recipients: current recommendations and protocols. Clin Microbiol Rev 2003;16:357-364.
7. Duchini A, Hendry RM, Redfield DC, Pockros PJ. Influenza infection before and after liver transplantation. Liver Transpl 2000;6:531-542.
8. Kunisaki KM, Janoff EN. Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses. Lancet Infect Dis 2009;9:493-504.
9. Duchini A, Hendry RM, Nyberg LM, Viernes ME, Pockros PJ. Immune response to influenza vaccine in adult liver transplant recipients. Liver Transpl 2001;7:311-313.
10. H1N1 vaccine for prevention of pandemic influenza. Med Lett Drugs Ther 2009;51:77-78.
11. Klimov AI, Rocha E, Hayden FG, Shult PA, Roumillat LF, Cox NJ. Prolonged shedding of amantadine-resistant influenzae A viruses by immunodeficient patients: detection by polymerase chain reaction-restriction analysis. J Infect Dis 1995;172:1352-1355.
12. Ison MG, Gubareva LV, Atmar RL, Treanor J, Hayden FG. Recovery of drug-resistant influenza virus from immunocompromised patients: a case series. J Infect Dis 2006;193:760-764.
13. Weinstock DM, Gubareva LV, Zuccotti G. Prolonged shedding of multidrug-resistant influenza A virus in an immunocompromised patient. N Engl J Med 2003;348: 867-868.
14. Centers for Disease Control and Prevention. Oseltamivir-resistant novel influenza A (H1N1) virus infection in two immunosuppressed patients - Seattle, Washington, 2009. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm58d0814a1.htm. Published August 14, 2009. Accessed January 2010.
15. Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5606a1.htm. Published July 13, 2007. Accessed January 2010.
16. Ison MG, Szakaly P, Shapira MY, Kriván G, Nist A, Dutkowski R. Oseltamivir prophylaxis significantly reduces the incidence of seasonal influenza infection in immunocompromised patients. http://www.themacraegroup. com/2009-symposia/xi-international-symposium-onrespiratory-viral-infections/ oral-abstracts/oseltamivirprophylaxis-significantly-reduces-the-incidence-of- seasonalinfluenza-infection-in-immunocompromized-patients. Accessed January 2010.